Reversal of P-glycoprotein-mediated multi-drug resistance by the E3 ubiquitin ligase Cbl-b in human gastric adenocarcinoma cells

J Pathol. 2009 Jun;218(2):248-55. doi: 10.1002/path.2533.

Abstract

P-glycoprotein (P-gp)-mediated multi-drug resistance (MDR) is a major barrier to the effective chemotherapy of many cancers. Recent studies have shown that inhibition of the PI3K/Akt signalling pathway can reverse P-gp-mediated MDR. We investigated the expression of activated Akt (p-Akt) in 124 human gastric carcinoma tissue samples. Ubiquitous p-Akt expression was recorded in the majority (88/124). There was a significant correlation between p-Akt expression and the expression of P-gp. In the adriamycin-resistant MDR gastric carcinoma cell line SGC7901/ADR, p-Akt expression was increased in comparison with the parental cell line SGC7901. Treatment of SGC7901/ADR cells with the PI3K inhibitor LY294002 reduced the expression of both p-Akt and P-gp. To explore the role of ubiquitin ligase Cbl-b in this regulatory pathway, SGC7901/ADR cells were transfected with a plasmid overexpressing wild-type Cbl-b. This down-regulated the expression of both p-Akt and P-gp. Furthermore, resistance to chemotherapeutic drugs was partially reversed. These results demonstrate an important role for Cbl-b in reversing P-gp-mediated gastric cancer MDR through suppression of the PI3K/Akt signalling pathway and the down-regulation of P-gp expression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / analysis
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / metabolism*
  • Adaptor Proteins, Signal Transducing / analysis
  • Adaptor Proteins, Signal Transducing / genetics*
  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / metabolism*
  • Adult
  • Antineoplastic Agents / therapeutic use
  • Apoptosis / drug effects
  • Cell Line, Tumor
  • Chromones / pharmacology
  • Doxorubicin / analysis
  • Doxorubicin / pharmacology
  • Drug Resistance, Multiple*
  • Female
  • Flow Cytometry
  • Gene Expression / drug effects
  • Gene Expression Profiling
  • Humans
  • Immunohistochemistry
  • Inhibitory Concentration 50
  • Male
  • Middle Aged
  • Morpholines / pharmacology
  • Oligonucleotide Array Sequence Analysis
  • Oncogene Protein v-akt / genetics
  • Oncogene Protein v-akt / metabolism
  • Phosphoinositide-3 Kinase Inhibitors
  • Proto-Oncogene Proteins c-cbl / analysis
  • Proto-Oncogene Proteins c-cbl / genetics*
  • Stomach Neoplasms / drug therapy
  • Stomach Neoplasms / metabolism*
  • Transfection / methods

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Adaptor Proteins, Signal Transducing
  • Antineoplastic Agents
  • Chromones
  • Morpholines
  • Phosphoinositide-3 Kinase Inhibitors
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • Doxorubicin
  • CBLB protein, human
  • Proto-Oncogene Proteins c-cbl
  • Oncogene Protein v-akt